Quantitative benefit-risk tradeoff preferences for Crohn's disease treatments – implications for regulatory decision making and disease management
Citation
Johnson, F., Hauber, A., Ozdemir, S., Hass, S., Siegel, C., & Sands, B. (2009). Quantitative benefit-risk tradeoff preferences for Crohn's disease treatments – implications for regulatory decision making and disease management. International Journal of Medical Biologic Frontiers, 15(5/6), 457 - 66.